Effectiveness of Myo-Inositol on Oocyte and Embryo Quality in Assisted Reproduction: Systematic Review and Meta-Analysis of Randomized Clinical Trials
Gynecologic and Obstetric Investigation · 2024
DOI: 10.1159/000540023 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Gynecologic and Obstetric Investigation, 2024. Verfasst von Laura Pivazyan und 5 weiteren Autor:innen. Beteiligte Einrichtung: FSBI, National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov, Ministry of Health of the Ru…. Hauptthemen laut MEDLINE: Inositol, Oocytes, Reproductive Techniques, Assisted, Embryo, Mammalian. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben.
Abstract (Originalsprache)
Introduction
We sought to conduct a systematic review and meta-analysis of randomized clinical trials (RCTs) to evaluate the impact of myo-inositol on oocyte and embryo quality in women undergoing assisted reproduction.
Methods
The systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 checklist (registration number: CRD42023433328). Studies were identified by searching PubMed, Cochrane Library, Google Scholar, Scopus, Embase, and ClinicalTrials databases.
Results
Eight RCTs were included for qualitative analysis reporting on 820 participants. Four meta-analyses were performed. Numbers of retrieved oocytes in comparison of intervention and control group were higher in inositol group (mean difference [MD] = 0.41, 95% CI: 0.05–0.77, p = 0.02). Meta-analysis of two studies comparing numbers of oocytes among poor ovarian responder patients showed no significant difference between intervention and control group (MD = 0.50, 95% CI: 0.57–1.58, p = 0.36). Miscarriage rate has no statistically significant difference between the treatment and control groups (risk ratios [RRs] = 0.81, 95% CI: 0.20–3.32, p = 0.77). Inositol played no role in improving clinical pregnancy rates; there was no significant difference between the intervention group and the control group (RR = 1.41, 95% CI: 0.88–2.25, p = 0.15).
Conclusion
Thus, we did not find any benefits of using myo-inositol on oocyte and embryo quality in women undergoing reproductive technologies. Further studies are needed to assess efficacy, safety, and high compliance by female patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- FSBI, National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov, Ministry of Health of the Russian Federation, Moscow, Russian Federation.
- FSBI, National Medical Research Center for Obstetrics, Gynecology and Perinatology named after academician V.I. Kulakov, Ministry of Health of the Russian Federation, Moscow, Russian Federation, Kr.katrin00@gmail.com.
- I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Zitieren
APA
Pivazyan, L., Krylova, E., Obosyan, L., Seregina, V., Shapovalenko, R., & Ayryan, E. (2024). Effectiveness of Myo-Inositol on Oocyte and Embryo Quality in Assisted Reproduction: Systematic Review and Meta-Analysis of Randomized Clinical Trials. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/000540023
Vancouver
Pivazyan L, Krylova E, Obosyan L, Seregina V, Shapovalenko R, Ayryan E. Effectiveness of Myo-Inositol on Oocyte and Embryo Quality in Assisted Reproduction: Systematic Review and Meta-Analysis of Randomized Clinical Trials. Gynecologic and Obstetric Investigation. 2024. doi:10.1159/000540023
BibTeX
@article{Pivazyan2024,
author = {Pivazyan, Laura and Krylova, Ekaterina and Obosyan, Lilia and Seregina, Valeriia and Shapovalenko, Roman and Ayryan, Eduard},
title = {Effectiveness of Myo-Inositol on Oocyte and Embryo Quality in Assisted Reproduction: Systematic Review and Meta-Analysis of Randomized Clinical Trials},
journal = {Gynecologic and Obstetric Investigation},
year = {2024},
doi = {10.1159/000540023}
}
EUVIMED